Research Article

Properties of Taurine Release in Glucose-Free Media in Hippocampal Slices from Developing and Adult Mice

Table 4

Effects of compounds involved in the second messenger systems on taurine release from mouse hippocampal slices in hypoxia.

Concentration (mM)Efflux rate constants (×10−3 min−1) ± SEM
3-month-old7-day-old

Basal (control) 2.36 ± 0.11(20)1.93 ± 0.18(11)1.34 ± 0.08(31)1.20 ± 0.11(11)
+50 mM K+ (control)2.92 ± 0.21(10)1.90 ± 0.10(12)

Genistein 0.0012.59 ± 0.13(7)2.06 ± 0.18(7)1.92 ± 0.16(7)1.44 ± 0.16(4)
+50 mM K+3.07 ± 0.25(4)2.27 ± 0.06(4)

Quinacrine 0.011.20 ± 0.08(7)0.83 ± 0.05(4)0.75 ± 0.07(8)0.61 ± 0.06(4)
+50 mM K+1.12 ± 0.13(4)0.79 ± 0.05(4)

PMA 0.000012.31 ± 0.20(8)1.77 ± 0.11(4)1.80 ± 0.15(8)1.33 ± 0.17(4)
+50 mM K+1.95 ± 0.17(4)1.85 ± 0.03(4)

Chelerythrine 0.0012.49 ± 0.17(7)2.07 ± 0.14(4)1.73 ± 0.18(8)1.53 ± 0.04(4)
+50 mM K+3.40 ± 0.51(4)2.01 ± 0.09(4)

IBMX 1.01.85 ± 0.16(8)2.51 ± 0.29(4)1.99 ± 0.24(6)1.33 ± 0.11(4)
+50 mM K+2.70 ± 0.13(4)1.85 ± 0.03(4)

RO 20-1724 0.23.46 ± 0.12(8)3.43 ± 0.15(4)1.96 ± 0.26(7)1.27 ± 0.17(4)
+50 mM K+4.56 ± 0.30(4)2.65 ± 0.33(4)

Zaprinast 0.12.31 ± 0.15(8)2.00 ± 0.20(8)1.00 ± 0.13(6)0.66 ± 0.12(4)
+50 mM K+2.53 ± 0.06(4)2.04 ± 0.23(4)

ODQ 0.012.51 ± 0.18(7)2.01 ± 0.13(4)1.50 ± 0.17(8)1.19 ± 0.08(8)
+50 mM K+2.50 ± 0.25(4)2.04 ± 0.06(4)

Alloxan 5.02.81 ± 0.31(7)2.19 ± 0.06(4)1.70 ± 0.17(6)1.58 ± 0.25(4)
+50 mM K+3.13 ± 0.10(4)1.86 ± 0.07(4)

The agonists were added at the beginning of the superfusion and 50 mM K+ at 30 min. The results show the efflux rate constants ± SEM (×10−3 min−1) for the time intervals of 20–30 min () and for 34–50 min without the excess of K+ or in the presence of 50 mM K+ () with the number of independent experiments in parenthesis. PMA: 4β-phorbol 12-myristate 13-acetate; IBMX: 3-isobutyl-1-methylxanthine; ODQ: 1H-1,2,4oxadiazolo4,3quinoxalin-1-one; RO 20-1724: 4-(3-butoxy-4-methoxyphenyl)-2-imidazolidone. Significance of differences from the corresponding controls: , .